The character arc of Quarraisha Abdool Karim

A life drawn by Character Arc from the public record

Born 20 March 1960 in Tongaat, South Africa, and educated under apartheid at a university designated for Indian South Africans. Between then and now sit a first degree in 1981, a master's at Columbia in 1988, a finding in 1992 that young women carried the heaviest burden of HIV, a doctorate at forty, years of a national government that disputed the science, and the trial that proved prevention was possible. The line below draws the story so far, in order.

Tap the line to pluck it. Hover or tap any mark for its card. Drawn from the public record of her life; the sources are at the foot of the page.

Who is Quarraisha Abdool Karim?

She had the answer in 1992, and waited to be heard.

She was born in Tongaat in 1960 and went to the University of Durban-Westville, which under apartheid was the institution designated for Indian South Africans. Her education was shaped by where the state permitted her to sit. She took honours at Witwatersrand, a master's in parasitology at Columbia in 1988, and eventually a doctorate in medicine at the University of Natal in 2000, at the age of forty.

In 1992 she published work showing that women, and particularly young women, were far more vulnerable to HIV infection than the prevailing understanding allowed for, and identified the role that patterns of migrant labour played in spreading it. It was the correct account of the epidemic in southern Africa, and it took years for prevention to be designed around it. Meanwhile the national government spent much of the following decade disputing the science of HIV and delaying access to treatment, while the epidemic ran.

She co-founded CAPRISA in 2002 and set out to prove that women could protect themselves. The CAPRISA 004 trial, run from 2007, tested an antiretroviral gel, and the results presented at the international AIDS conference in July 2010 showed a thirty nine per cent reduction in infections. The room stood up. Science named it one of the breakthroughs of the year. She holds a professorship at Columbia and a pro vice chancellorship at KwaZulu-Natal, received the Lasker Bloomberg Public Service Award in 2024 with her husband Salim, and was elected a Fellow of the Royal Society in 2025. Her line is worth reading because being right in 1992 bought her nothing for eighteen years.

The moments

Quarraisha Abdool Karim's timeline.

The 1980s

~1981

A degree at Durban-Westville

Milestone, and it changed everything. Where she was allowed to study was decided by the state, not by her results.

Jun 1988

A master's at Columbia

Milestone, and it changed her direction. The training in New York that made her an epidemiologist rather than a bench scientist.

The 1990s

~1992

Young women, and nobody listened

Milestone, and it changed everything. She described the shape of the southern African epidemic correctly, and prevention was not redesigned around it for years.

The 2000s

~2000

A doctorate in medicine

Milestone. The doctorate came at forty, eight years after the finding she is best known for.

Jun 2000

A government that denied it

Setback, and it changed everything. She was doing HIV research in a country whose government was arguing with the premise of it.

1 Jun 2001

Argue the science, or prove it

Crossroads, decided.

The paths laid out: build an institute and run the trial, taken, or keep making the case. CAPRISA was founded in 2002 and its 004 trial produced, in 2010, the first proof that an antiretroviral gel could reduce HIV infection in women.

~2002

She co-founded CAPRISA

Milestone, and it changed everything. Her own institution, built to run the trials that would settle the question rather than argue it.

~2007

The CAPRISA 004 trial

Milestone, and it changed everything. A trial designed for the people her 1992 work had identified, fifteen years after she identified them.

The 2010s

Jul 2010

A standing ovation in Vienna

Milestone, and it changed everything. The first proof that a woman could protect herself from HIV with something she controlled. The room stood up.

~2016

The L Oreal UNESCO award

Milestone. International recognition, twenty four years after the finding.

The 2020s

~2020

The Gairdner Global Health Award

Milestone. One of the awards that most often precedes a Nobel Prize in medicine.

Sep 2024

The Lasker Award

Milestone, and it changed everything. One of the highest honours in medicine, given to her and her husband together for the same body of work.

~2025

Fellow of the Royal Society

Milestone, and it changed everything. Admitted to the oldest scientific academy in continuous existence, at sixty five.

The line reaches today still adding to itself, which is why it is drawn now rather than at the end. What it has set moving is the reason HIV prevention is now designed around the people it actually reaches first, and the reason a young woman in KwaZulu-Natal has something to use.

Your turn

Every line draws a unique story.

Hers was correct for nearly two decades before anybody acted on it. Yours is already further along than you think, and drawing it takes about five minutes.

Step through

Draw my own line Explore Character Arc

Quarraisha Abdool Karim: frequently asked questions

What people ask about her line.

What is Quarraisha Abdool Karim's character arc?

Being right early and waiting to be heard. Born in South Africa in 1960 and educated under apartheid, she showed in 1992 that young women carried the heaviest HIV burden, co-founded CAPRISA in 2002, and proved in 2010 that women could protect themselves.

What were the turning points in Quarraisha Abdool Karim's life?

The 1992 finding about young women and HIV set everything that followed. Founding CAPRISA in 2002 changed her from someone making an argument to someone producing evidence, and the trial results presented in July 2010 changed HIV prevention worldwide.

What did Quarraisha Abdool Karim discover?

First, in 1992, that women and particularly young women were far more vulnerable to HIV than the prevailing understanding allowed, and that migrant labour patterns drove transmission. Later, through the CAPRISA 004 trial, that an antiretroviral gel could cut infections by thirty nine per cent.

What was Quarraisha Abdool Karim's biggest setback?

The years in which nothing was done with what she knew. She described the epidemic correctly in 1992, and for much of the following decade the national government disputed the established science of HIV and delayed access to treatment while the epidemic ran.

What is CAPRISA, and what did Quarraisha Abdool Karim do there?

The Centre for the AIDS Programme of Research in South Africa, which she co-founded in 2002 and where she is Associate Scientific Director. It ran the CAPRISA 004 trial from 2007, whose results in 2010 were named by Science among the breakthroughs of the year.

What awards has Quarraisha Abdool Karim won?

The L'Oreal UNESCO Award for Women in Science in 2016, the Canada Gairdner Global Health Award in 2020, and the Lasker Bloomberg Public Service Award in 2024, shared with her husband Salim. She was elected a Fellow of the Royal Society in 2025.

Where was Quarraisha Abdool Karim educated?

At the University of Durban-Westville, which under apartheid was the institution designated for Indian South Africans, where she took a first degree in 1981. She went on to honours at Witwatersrand, a master's at Columbia in 1988 and a doctorate at the University of Natal in 2000.

Where does this timeline of Quarraisha Abdool Karim's life come from?

From the public record. Character Arc drew every moment on this line from the sources listed at the foot of the page, and the kind and weight of each moment are our editorial reading. Quarraisha Abdool Karim isn't a Member of Character Arc and has no connection with it, and no feeling is attributed to her.

More character arcs

Lives that rhyme with her.

Every Character, A to Z

Sources

Quarraisha Abdool Karim, English Wikipedia biography.
CAPRISA 004 trial results, presented at the International AIDS Conference, July 2010.
Lasker Bloomberg Public Service Award, 2024.